Drug-induced hepatitis: Epidemiological, clinical, diagnostic, and pathophysiological aspects (notice n° 152431)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01867cam a2200241 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250112030512.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Moukafih, Badreddine |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Drug-induced hepatitis: Epidemiological, clinical, diagnostic, and pathophysiological aspects |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2023.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 34 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Although drug-induced liver injury is a rare clinical event, it causes significant morbidity and mortality, making it the leading cause of acute liver failure. The predominant clinical presentation is acute hepatitis and/or cholestasis, although almost any clinical pathological pattern of acute or chronic liver disease can occur. The pathogenesis of drug-induced liver disease usually involves the drug or metabolites that directly affect cellular biochemistry or elicit an immune response. Susceptibility to drug-induced hepatotoxicity is also influenced by genetic and environmental risk factors. Unpredictable, low-frequency, and idiosyncratic reactions often occur in the context of high levels of mild asymptomatic liver damage and, although difficult to predict, can be detected by monitoring serum alanine aminotransferase levels. The development of various drug-injury networks has played a key role in expanding our knowledge of liver injury associated with drugs, herbs, and dietary supplements. |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bandadi, Fatimazahra |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | El Marrakchi, Soufiane |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bennani, Ismail |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Nchinech, Nawal |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hafidi, Youssef |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Achour, Sanae |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | El Kartouti, Abdeslam |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Cahiers Santé Médecine Thérapeutique | 32 | 5 | 2023-09-01 | p. 216-222 | 2780-8858 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/journal-cahiers-sante-medecine-therapeutique-2023-5-page-216?lang=en">https://shs.cairn.info/journal-cahiers-sante-medecine-therapeutique-2023-5-page-216?lang=en</a> |
Pas d'exemplaire disponible.
Réseaux sociaux